Guide for Authors

  • Instructions for Authors (pdf)

    The Journal of Urology® contains 4 sections: Adult Urology, PediatricUrology, Investigative Urology and Urological Survey. Rapid Communicationsare welcomed. The Adult and Pediatric Urology Sections (originalarticles) usually do not publish laboratory animal studies. The Investigative Urology Section (research articles) does not publish clinically oriented articles,and does not require prior approval for Review Articles. Unsolicited materialis not accepted for Urological Survey.

    All communications concerning editorial matters should be sent to:

    The Journal of Urology®
    Publications Department
    American Urological Association
    1000 Corporate Boulevard
    Linthicum, MD 21090
    Telephone (410) 689-3922, FAX (410) 689-3906
    e-mail: publications@auanet.org

    MANUSCRIPT SUBMISSION. Authors must submit their manuscriptsthrough the Web-based tracking system at https://www.editorialmanager.com/ju . The site contains instructions and advice on how to use the system,guidance on the creation/scanning and saving of electronic art, and supportingdocumentation. In addition to allowing authors to submit manuscripts on theWeb, the site allows authors to follow the progression of their manuscriptthrough the peer review process. Authors are asked NOT to mail hard copiesof the manuscript to the editorial office. They may, however, mail to theeditorial office any material that cannot be submitted electronically.

    For potentially acceptable manuscripts, the period between receiptof all reviews and when an editorial decision is made is usuallylonger.

    AUTHOR'S RESPONSIBILITY. Manuscripts must be accompanied by acover letter, an AUA Disclosure Form and an Author Submission Requirement Form (see last page) signed by all authors. The letter should include the completeaddress, telephone number, FAX number and e-mail address of the designatedcorresponding author as well as the names of potential reviewers. The correspondingauthor is responsible for indicating the source of extra-institutionalfunding, in particular that provided by commercial sources, internal reviewboard approval of study, accuracy of the references and all statements made intheir work, including changes made by the copy editor.

    Manuscripts submitted without all signatures on all statementswill be returned to the authors immediately. Electronic signatures areacceptable.

    Authors are expected to submit complete and correct manuscripts. Due tothe large number of high quality articles being submitted and to avoid significantdelay in publication, the Editors find it necessary to insist that thelength of manuscripts, and number of references and illustrations conform tothe requirements indicated herein. No paper will be reviewed until theserequirements are met. Published manuscripts become the sole property of The Journal of Urology® and copyright will be taken out in the name of theAmerican Urological Association Education and Research, Inc.

    All accepted NIH funded articles must be directly deposited toPubMed Central by the authors of the article for public access 12months after the publication date.

    PAGE PROOFS AND CORRECTIONS. The corresponding author willreceive electronic page proofs to check the typeset article before publication.Portable document format (PDF) files of the typeset pages and support documents(eg, reprint order form) will be sent to the corresponding author bye-mail. Complete instructions will be provided with the e-mail for downloadingand printing the files and for faxing the corrected page proofs to theeditorial office.

    It is the author's responsibility to ensure that there are no errors in theproofs. Changes that have been made to conform to journal style will stand ifthey do not alter the author's meaning. Only the most critical changes to theaccuracy of the content will be made. Changes that are stylistic or are areworking of previously accepted material will be disallowed. The editorialoffice reserves the right to disallow extensive alterations. Authors may becharged for alterations to the proofs beyond those required to correct errors orto answer queries. Proofs must be checked carefully and corrections faxedwithin 24 to 48 hours of receipt, as requested in the cover letter accompanyingthe page proofs.

    Rapid Review Manuscripts that contain important and timely informationwill be reviewed by 2 consultants and the editors within 72 hours ofreceipt, and authors will be notified of the disposition immediately thereafter. The authors must indicate in their submittal letter why they believe their manuscript warrants rapid review. A $250 processing fee should be forwarded with the manuscript at thetime of submission. Checks should be made payable to the American UrologicalAssociation. If the editors decide that the paper does not warrant rapidreview, the fee will be returned to the authors, and they may elect to have themanuscript continue through the standard review process. Payment for rapidreview guarantees only an expedited review and not acceptance.

    Original and Research Articles should be arranged as follows:Title Page, Abstract, Introduction, Materials and Methods, Results,Discussion, Conclusions, References, Tables, Legends. The title page shouldcontain a concise, descriptive title, the names and affiliations of all authors,and a brief descriptive runninghead not to exceed 50 characters. One to fivekey words should be typed at the bottom of the title page. These words shouldbe identical to the medical subject headings (MeSH) that appear in the IndexMedicus of the National Library of Medicine. The abstract should not exceed250 words and must conform to the following style: Purpose, Materials andMethods, Results and Conclusions.

    References should not exceed 30 readily available citations for all articles(except Review Articles). Self-citations should be kept to a minimum.References should be cited by superscript numbers as they appear in the text,and they should not be alphabetized. References should include the namesand initials of the first 3 authors, the complete title, the abbreviated journal name according to the Index Medicus of the National Library of Medicine, thevolume, the beginning page number and the year. References to book chaptersshould include names and initials of the first 3 chapter authors, chapter title,book title and edition, names and initials of the first 3 book editors, city ofpublisher, publisher, volume number, chapter number, page range and year.In addition to the above, references to electronic publications should includetype of medium, availability statement and date of accession. The statisticalmethods should be indicated and referenced. Enough information should bepresented to allow an independent critical assessment of the data.

    Digital illustrations and tables should be kept to a necessary minimumand their information should not be duplicated in the text. No more than10 illustrations should accompany the manuscript for clinical articles. Magnificationsfor photomicrographs should be supplied and graphs should belabeled clearly. Reference to illustrations, numbered with Arabic numerals,must be provided in the text. Blurry or unrecognizable illustrations are notacceptable. Visit http://rapidinspector.cadmus.com/zww for detailed instructionsfor digital art. The use of color is encouraged at no charge to the authors.

    Tables should be numbered and referred to in the text. In general, theyshould present summarized rather than individual raw data. Due to pageconstraints caused by the large number of high quality manuscripts beingsubmitted to The Journal of Urology, the editors find it necessary to offerpublishing alternatives. Therefore, authors may be requested to post tables assupplementary material on their institution's website at no charge or on TheJournal website at a per page rate of $79. Authors may also elect to print theirtables with the article at a per page rate of $236.

    Letters to the Editor should be useful to urological practitioners. Thelength should not exceed 500 words. Only Letters concerning articles publishedin the Journal within the last year are considered.

    Review Articles should not be submitted without prior approval. Queriesfor these articles should be accompanied by a detailed outline of theproposed article, an abstract not to exceed 750 words and an estimate of thelength of the manuscript to be submitted. The format is the same as that of anOriginal Article.

    Special Articles are scientific reports of original clinical research andstate-of-the-art topics, and are designated as such by the Editors. The formatis the same as that of an Original Article.

    New Technology and Techniques feature high quality manuscripts that describe the innovative clinical application of new technology or techniques in all disciplines of urology, and are designated as such by the Editors. Addressing diagnosis or management of urological conditions, this feature covers the categories of 1) cutting-edge technology, 2) novel/modified techniques and 3) outcomes data derived from use of 1 and/or 2. The format is the same as that of an Original Article, although fewer words are preferred to allow more space for illustrations.

    Opposing Views are submitted by invitation only.

    Video Clips may be submitted for posting on The Journal web site. Theyare subject to peer review. Video files must be compressed to the smallestpossible size that still allows for high resolution and quality presentation. Thesize of each clip should not exceed 10MB. File size limitation is intended toensure that end-users are able to download and view files in a reasonable timeframe. If files exceed the specified size limitation, they will not be posted to theweb site and returned to the author for resubmission. For complete instructionse-mail:publications@auanet.org.

    checklist


    Recommendations

    1. All subgroup analyses and covariate inclusions should be motivated prior to the Results section. Hypotheses which were notestablished prior to initial analyses should be clearly identified.
    2. Variables should be clearly defined, such as specific assays, references for staging, references for validation of surveyinstruments, etc.
    3. Treatment regimens should be described well enough for another study to replicate.
    4. It should be clear which statistical test is associated with each p value reported.
    5. Rarely used statistical techniques should be described.
    6. Medians and percentiles (such as quartiles) are preferred over means and standard deviations (or standard errors) whenanalyzing asymmetric data, especially when nonparametric statistics are calculated.
    7. Fractions (eg, 5/10) should accompany percentages.
    8. In randomized clinical trials, consider reporting separate analyses with confounding variables included.
    9. If sample sizes differ between groups when patients are randomized, reasons should be provided.
    10. Report median survival (using Kaplan-Meier) rather than mean survival if any data are censored.
    11. Comparing survival functions (eg, with a log rank test) is more efficient than analyzing particular time estimates (eg, 5-yearsurvival).
    12. Use appropriate figures. Scatter plots are useful for illustrating important correlations between variables. If subjects arerepeated in a figure (eg, over time), an individual's set of points should be joined with line segments. Different symbols shouldbe used when points are stacked on top of each other. Illustrations of regression lines should be overlaid on raw data.Regression lines should not extend beyond the range of the predictor variable.
    13. Confidence intervals are more appropriate than standard errors for comparison of groups.
    14. Use appropriate tables. Coefficients and standard errors are useful for interpreting regression predictors. One significantfigure beyond the level measured is sufficient for means, standard deviations, standard errors, etc. One decimal place forpercentages greater than 1% is sufficient; no decimal places if the sample size is less than 100. Two significant figures for teststatistics and p values are sufficient. Means should generally be accompanied by some measure of their uncertainty, such asconfidence intervals or standard errors.
    15. Confidence intervals should be reported when possible.
    16. When a statistical hypothesis test is not rejected, the actual p value (eg, 0.07) should be reported (if known) rather than omittedor reported as p >0.05.
    17. Pay close attention to wording. The word 'correlation' is generally reserved for computing correlation coefficients. The word'association' is usually preferred. Statistical tests can be nonparametric; data cannot. Studies with negative findings (ie, nodifference) may be the result of low statistical power (eg, small sample size), rather than absence of a difference, and thislimitation should be made clear. Trends that are not statistically significant should not be identified. A p value is theprobability of observing data as extreme as those reported if the null hypothesis of no difference is true. A p value is not theprobability of no real effect, nor is it necessarily related to the clinical importance.


    Manuscript Checklist

    • 1. Author Submission Requirement form has been signed by all authors.
    • 2. AUA Disclosure Form has been signed by all authors.
    • 3. Manuscript word count is provided.
    • 4. Manuscript does not exceed 2,500 words for Original Article.
    • 5. Manuscript does not exceed 3,000 words for Research Article.
    • 6. Manuscript does not exceed 500 words for Letter to the Editor.
    • 7. Manuscript does not exceed 1,000 words for Opposing Views.
    • 8. No more than 10 illustrations submitted.
    • 9. Standard abbreviations are defined in a key at the end of the manuscript, and are consistent throughout the text.
    • 10. Generic names are used for all drugs. Trade names are avoided.
    • 11. Normal laboratory values are provided in parentheses when first used.
    • 12. Research or project support/funding is noted.
    • 13. Internal review board approval of study is indicated.
    • 14. Registration number of clinical trial provided.
    • 15. References are accurate, complete and in numerical order as they appear in the text, only the first 3 authors are listed.
    • 16. No more than 30 references are cited, including references from the last 3 years.
    • 17. A corresponding author and complete address, telephone and FAX numbers and e-mail address are provided.
    • 18. Written permission from publishers to reproduce or adapt previously published illustrations or tables is included.
    • 19. Informed consent forms for identifiable patient descriptions, photographs and pedigrees are included.
    • 20. Analytical reporting checklist completed.
    • 21. Gender and minorities are identified in collection and analyses of data.
    • 22. Abbreviations for human genes are written in italicized capital letters; protein products are written in capital letters andare not italicized.
    • 23. Abbreviations for animal genes are written in italics with only the first letter capitalized; protein products are written withonly the first letter capitalized and are not italicized.
    • 24. Name of validated system used for reporting complications/outcomes provided.

    Disclosure Statement

    Submission Requirement

    Updated February 2013

Advertisement

advert image